NCT05282550View on ClinicalTrials.gov

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

July 30, 2027

Study Completion Date

June 30, 2028

Conditions
AMCI - Amnestic Mild Cognitive ImpairmentSleep Disturbance
Interventions
DRUG

Trazodone

50mg of trazodone administered for 4 weeks.

DRUG

Placebo

Placebo administered for 4 weeks.

Trial Locations (1)

21205

RECRUITING

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Johns Hopkins University

OTHER